A Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors.
Saved in:
| Title: | A Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors. |
|---|---|
| Authors: | Uronis, Hope1, Jia, Jingquan, Bendell, Johanna2, Howard, Leigh1, Ready, Neal1, Lee, Paula1, Starr, Mark1, Dellinger, Andrew, Pang, Herbert, Nixon, Andrew1, Hurwitz, Herbert1 hurwi004@mc.duke.edu |
| Source: | Cancer Chemotherapy & Pharmacology. Feb2015, Vol. 75 Issue 2, p343-352. 10p. |
| Database: | Academic Search Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 100632265 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Uronis%2C+Hope%22">Uronis, Hope</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Jia%2C+Jingquan%22">Jia, Jingquan</searchLink><br /><searchLink fieldCode="AR" term="%22Bendell%2C+Johanna%22">Bendell, Johanna</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Howard%2C+Leigh%22">Howard, Leigh</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Ready%2C+Neal%22">Ready, Neal</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Lee%2C+Paula%22">Lee, Paula</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Starr%2C+Mark%22">Starr, Mark</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Dellinger%2C+Andrew%22">Dellinger, Andrew</searchLink><br /><searchLink fieldCode="AR" term="%22Pang%2C+Herbert%22">Pang, Herbert</searchLink><br /><searchLink fieldCode="AR" term="%22Nixon%2C+Andrew%22">Nixon, Andrew</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Hurwitz%2C+Herbert%22">Hurwitz, Herbert</searchLink><relatesTo>1</relatesTo><i> hurwi004@mc.duke.edu</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Cancer+Chemotherapy+%26+Pharmacology%22">Cancer Chemotherapy & Pharmacology</searchLink>. Feb2015, Vol. 75 Issue 2, p343-352. 10p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=100632265 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00280-014-2647-x Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 10 StartPage: 343 Titles: – TitleFull: A Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Uronis, Hope – PersonEntity: Name: NameFull: Jia, Jingquan – PersonEntity: Name: NameFull: Bendell, Johanna – PersonEntity: Name: NameFull: Howard, Leigh – PersonEntity: Name: NameFull: Ready, Neal – PersonEntity: Name: NameFull: Lee, Paula – PersonEntity: Name: NameFull: Starr, Mark – PersonEntity: Name: NameFull: Dellinger, Andrew – PersonEntity: Name: NameFull: Pang, Herbert – PersonEntity: Name: NameFull: Nixon, Andrew – PersonEntity: Name: NameFull: Hurwitz, Herbert IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: Feb2015 Type: published Y: 2015 Identifiers: – Type: issn-print Value: 03445704 Numbering: – Type: volume Value: 75 – Type: issue Value: 2 Titles: – TitleFull: Cancer Chemotherapy & Pharmacology Type: main |
| ResultId | 1 |
